Cargando…
Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study
OBJECTIVE: To assess the association between the use of sodium glucose cotransporter 2 (SGLT2) inhibitors and seven serious adverse events of current concern. DESIGN: Register based cohort study. SETTING: Sweden and Denmark from July 2013 to December 2016. PARTICIPANTS: A propensity score matched co...
Autores principales: | Ueda, Peter, Svanström, Henrik, Melbye, Mads, Eliasson, Björn, Svensson, Ann-Marie, Franzén, Stefan, Gudbjörnsdottir, Soffia, Hveem, Kristian, Jonasson, Christian, Pasternak, Björn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233755/ https://www.ncbi.nlm.nih.gov/pubmed/30429124 http://dx.doi.org/10.1136/bmj.k4365 |
Ejemplares similares
-
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
por: Pasternak, Björn, et al.
Publicado: (2019) -
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
por: Pasternak, Björn, et al.
Publicado: (2020) -
Use of incretin-based drugs and risk of cholangiocarcinoma: Scandinavian cohort study
por: Ueda, Peter, et al.
Publicado: (2021) -
Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study
por: Inghammar, Malin, et al.
Publicado: (2016) -
Impact of ethnicity on progress of glycaemic control in 131 935 newly diagnosed patients with type 2 diabetes: a nationwide observational study from the Swedish National Diabetes Register
por: Rawshani, Araz, et al.
Publicado: (2015)